{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:35:04Z","timestamp":1766208904355,"version":"3.48.0"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.2169\/internalmedicine.5196-24","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:07:26Z","timestamp":1750270046000},"page":"3537-3541","source":"Crossref","is-referenced-by-count":0,"title":["Progressive Renal Dysfunction in Autosomal-dominant Alport Syndrome Co-occurring with C1q Nephropathy"],"prefix":"10.2169","volume":"64","author":[{"given":"Kasumi","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fujimaru","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"},{"name":"Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Itabashi Chuo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumika","family":"Taki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Chiga","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Institute of Science Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisei","family":"Sohara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St. Luke&apos;s International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kashtan CE. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine (Baltimore) 78: 338-360, 1999.","DOI":"10.1097\/00005792-199909000-00005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lee JM, Nozu K, Choi DE, Kang HG, Ha IS, Cheong HI. Features of autosomal recessive Alport syndrome: a systematic review. J Clin Med 8: 178, 2019.","DOI":"10.3390\/jcm8020178"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Furlano M, Mart\u00ednez V, Pybus M, et al. Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study. Am J Kidney Dis 78: 560-570.e1, 2021.","DOI":"10.1053\/j.ajkd.2021.02.326"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kamiyoshi N, Nozu K, Fu XJ, et al. Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome. Clin J Am Soc Nephrol 11: 1441-1449, 2016.","DOI":"10.2215\/CJN.01000116"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Villar MT, Bass P, Dewhurst G, Theaker JM, Dathan JR. Autosomal dominant polycystic kidney disease complicated by glomerulonephritis. Nephron 62: 226-228, 1992.","DOI":"10.1159\/000187038"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Araki Y, Kawaguchi A, Sakakibara N, et al. Poststreptococcal acute glomerulonephritis can be a risk factor for accelerating kidney dysfunction in Alport syndrome: a case experience. CEN Case Rep 9: 418-422, 2020.","DOI":"10.1007\/s13730-020-00498-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bhattacharyya A, Huang Y, Khan SH, Drachenberg CB, Malone LC. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report. BMC Nephrol 22: 358, 2021.","DOI":"10.1186\/s12882-021-02567-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ding Y, Tang X, Du Y, et al. Co-existence of Alport syndrome and C3 glomerulonephritis in a proband with family history. Eur J Med Res 26: 71, 2021.","DOI":"10.1186\/s40001-021-00543-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mori T, Hosomichi K, Chiga M, et al. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel. Clin Exp Nephrol 21: 63-75, 2017.","DOI":"10.1007\/s10157-016-1252-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mori T, Chiga M, Fujimaru T, et al. Phenotypic differences of mutation-negative cases in Gitelman syndrome clinically diagnosed in adulthood. Hum Mutat 42: 300-309, 2021.","DOI":"10.1002\/humu.24159"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17: 405-424, 2015.","DOI":"10.1038\/gim.2015.30"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Jennette JC, Hipp CG. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 83: 415-420, 1985.","DOI":"10.1093\/ajcp\/83.4.415"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Markowitz GS, Schwimmer JA, Stokes MB, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64: 1232-1240, 2003.","DOI":"10.1046\/j.1523-1755.2003.00218.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vizjak A, Ferluga D, Rozic M, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19: 2237-2244, 2008.","DOI":"10.1681\/ASN.2007080929"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kim K, Son HE, Ryu JY, et al. C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics. PLoS One 14: e0215217, 2019.","DOI":"10.1371\/journal.pone.0215217"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Oka M, Nozu K, Kaito H, et al. Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol 29: 1535-1544, 2014.","DOI":"10.1007\/s00467-014-2797-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wickman L, Hodgin JB, Wang SQ, Afshinnia F, Kershaw D, Wiggins RC. Podocyte depletion in thin GBM and Alport syndrome. PLoS One 11: e0155255, 2016.","DOI":"10.1371\/journal.pone.0155255"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Savige J. Heterozygous pathogenic <i>COL4A3<\/i> and <i>COL4A4<\/i> variants (autosomal dominant Alport syndrome) are common, and not typically associated with end-stage kidney failure, hearing loss, or ocular abnormalities. Kidney Int Rep 7: 1933-1938, 2022.","DOI":"10.1016\/j.ekir.2022.06.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Savige J, Harraka P. Pathogenic variants in the genes affected in Alport syndrome (<i>COL4A3<\/i>-<i>COL4A5<\/i>) and their association with other kidney conditions: a review. Am J Kidney Dis 78: 857-864, 2021.","DOI":"10.1053\/j.ajkd.2021.04.017"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/24\/64_5196-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T03:39:46Z","timestamp":1766201986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/24\/64_5196-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":19,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5196-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"5196-24"}}